Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease.

Gibson DJ, Ward MG, Rentsch C, Friedman AB, Taylor KM, Sparrow MP, Gibson PR.

Aliment Pharmacol Ther. 2020 Mar;51(6):612-628. doi: 10.1111/apt.15643. Epub 2020 Jan 21. Review.

PMID:
31961001
2.

Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.

Sparrow MP, Papamichael K, Ward MG, Riviere P, Laharie D, Paul S, Roblin X.

J Crohns Colitis. 2019 Sep 24. pii: jjz162. doi: 10.1093/ecco-jcc/jjz162. [Epub ahead of print]

PMID:
31549158
3.

Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis.

Little RD, Chu IE, van der Zanden EP, Flanagan E, Bell SJ, Gibson PR, Sparrow MP, Shelton E, Connor SJ, Roblin X, Ward MG.

J Crohns Colitis. 2019 Dec 10;13(12):1527-1536. doi: 10.1093/ecco-jcc/jjz103.

PMID:
31094417
4.

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy-early promise but more data needed.

Gibson DJ, Ward MG.

Aliment Pharmacol Ther. 2019 Mar;49(6):816-817. doi: 10.1111/apt.15081. No abstract available.

PMID:
30811645
5.

Apoptotic β-cells induce macrophage reprogramming under diabetic conditions.

Ward MG, Li G, Hao M.

J Biol Chem. 2018 Oct 19;293(42):16160-16173. doi: 10.1074/jbc.RA118.004565. Epub 2018 Sep 13.

6.

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions.

Ward MG, Sparrow MP, Roblin X.

Therap Adv Gastroenterol. 2018 May 8;11:1756284818772786. doi: 10.1177/1756284818772786. eCollection 2018. Review.

7.

Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline.

Su HY, Ward MG, Sparrow MP.

Transl Gastroenterol Hepatol. 2017 Dec 19;2:113. doi: 10.21037/tgh.2017.12.05. eCollection 2017. No abstract available.

8.

Inadequate storage of subcutaneous biological agents by patients with inflammatory bowel disease: Another factor driving loss of response?

Rentsch C, Headon B, Ward MG, Gibson PR.

J Gastroenterol Hepatol. 2018 Jan;33(1):10-11. doi: 10.1111/jgh.14001. No abstract available.

PMID:
29284080
9.

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13. Review.

10.

Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion.

Ward MG, Li G, Barbosa-Lorenzi VC, Hao M.

Sci Rep. 2017 Aug 25;7(1):9536. doi: 10.1038/s41598-017-10209-0.

11.
12.

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people? Authors' reply.

Ward MG, Irving PM.

Aliment Pharmacol Ther. 2017 Aug;46(4):465. doi: 10.1111/apt.14209. No abstract available.

13.

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety.

Ward MG, Patel KV, Kariyawasam VC, Goel R, Warner B, Elliott TR, Blaker PA, Irving PM, Marinaki AM, Sanderson JD.

United European Gastroenterol J. 2017 Jun;5(4):563-570. doi: 10.1177/2050640616663438. Epub 2016 Aug 1.

14.

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.

Ward MG, Warner B, Unsworth N, Chuah SW, Brownclarke C, Shieh S, Parkes M, Sanderson JD, Arkir Z, Reynolds J, Gibson PR, Irving PM.

Aliment Pharmacol Ther. 2017 Jul;46(2):150-161. doi: 10.1111/apt.14124. Epub 2017 May 8.

15.

Editorial: variability in adalimumab trough and peak serum concentrations - authors' reply.

Ward MG, Gibson PR, Sparrow MP.

Aliment Pharmacol Ther. 2017 Jun;45(11):1476-1477. doi: 10.1111/apt.14091. No abstract available.

16.

Effect on Rendement Napole genotype on metabolic markers in Ossabaw pigs fed different levels of fat.

Lu H, Yan H, Ward MG, Stewart T, Adeola O, Ajuwon KM.

J Anim Physiol Anim Nutr (Berl). 2018 Feb;102(1):e132-e138. doi: 10.1111/jpn.12720. Epub 2017 Apr 28.

PMID:
28455882
17.

Is there a role for thioguanine therapy in IBD in 2017 and beyond?

Taylor KM, Ward MG, Blaker PA, Sparrow MP.

Expert Rev Gastroenterol Hepatol. 2017 May;11(5):473-486. doi: 10.1080/17474124.2017.1294062. Epub 2017 Feb 20. Review.

PMID:
28276819
18.

Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease.

Ward MG, Thwaites PA, Beswick L, Hogg J, Rosella G, Van Langenberg D, Reynolds J, Gibson PR, Sparrow MP.

Aliment Pharmacol Ther. 2017 Apr;45(8):1135-1145. doi: 10.1111/apt.13992. Epub 2017 Feb 27.

19.

Multifunctional in vivo imaging of pancreatic islets during diabetes development.

Li G, Wu B, Ward MG, Chong AC, Mukherjee S, Chen S, Hao M.

J Cell Sci. 2016 Jul 15;129(14):2865-75. doi: 10.1242/jcs.190843. Epub 2016 Jun 6.

20.

Effects of dietary resistant starch content on metabolic status, milk composition, and microbial profiling in lactating sows and on offspring performance.

Yan H, Lu H, Almeida VV, Ward MG, Adeola O, Nakatsu CH, Ajuwon KM.

J Anim Physiol Anim Nutr (Berl). 2017 Feb;101(1):190-200. doi: 10.1111/jpn.12440. Epub 2016 Feb 5.

PMID:
26848026
21.

How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?

Ward MG, Irving PM, Sparrow MP.

World J Gastroenterol. 2015 Oct 28;21(40):11331-42. doi: 10.3748/wjg.v21.i40.11331. Review.

22.

Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease.

Ward MG, Kariyawasam VC, Mogan SB, Patel KV, Pantelidou M, Sobczyńska-Malefora A, Porté F, Griffin N, Anderson SH, Sanderson JD, Harrington DJ, Irving PM.

Inflamm Bowel Dis. 2015 Dec;21(12):2839-47. doi: 10.1097/MIB.0000000000000559.

PMID:
26296064
23.

Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis.

Ward MG, Sparrow MP.

Aliment Pharmacol Ther. 2014 Sep;40(6):730-1. doi: 10.1111/apt.12896. No abstract available.

24.

Case 1: A 12-year-old girl with food allergies and an acute asthma exacerbation.

Das L, Ward MG.

Paediatr Child Health. 2014 Feb;19(2):69-70. No abstract available.

25.

The medical assessment of bruising in suspected child maltreatment cases: A clinical perspective.

Ward MG, Ornstein A, Niec A, Murray CL; Canadian Paediatric Society, Child and Youth Maltreatment Section.

Paediatr Child Health. 2013 Oct;18(8):433-42. English, French. Erratum in: Paediatr Child Health. 2013 Nov;18(9):456.

26.

From bruises to brain injury: The physician's role in the assessment of inflicted traumatic head injury.

Ward MG, King WJ, Bennett S.

Paediatr Child Health. 2013 Oct;18(8):423-4. No abstract available.

27.

Regulation of adipocyte differentiation and gene expression-crosstalk between TGFβ and wnt signaling pathways.

Lu H, Ward MG, Adeola O, Ajuwon KM.

Mol Biol Rep. 2013 Sep;40(9):5237-45. doi: 10.1007/s11033-013-2623-2. Epub 2013 May 9.

PMID:
23657601
28.

Biglycan deletion alters adiponectin expression in murine adipose tissue and 3T3-L1 adipocytes.

Ward MG, Ajuwon KM.

PLoS One. 2012;7(11):e50554. doi: 10.1371/journal.pone.0050554. Epub 2012 Nov 26.

29.

Clinical and radiographic characteristics associated with abusive and nonabusive head trauma: a systematic review.

Piteau SJ, Ward MG, Barrowman NJ, Plint AC.

Pediatrics. 2012 Aug;130(2):315-23. doi: 10.1542/peds.2011-1545. Epub 2012 Jul 9. Review.

PMID:
22778309
30.

Child protection: a neglected area of pediatric residency training.

Ward MG, Bennett S, Plint AC, King WJ, Jabbour M, Gaboury I.

Child Abuse Negl. 2004 Oct;28(10):1113-22.

PMID:
15519439
31.

Prevention of shaken baby syndrome: Never shake a baby.

Ward MG, Bennett S, King WJ.

Paediatr Child Health. 2004 May;9(5):319-21.

32.

HIV-1 infection in a small animal human vaginal xenograft model.

Kish TM, Ward MG, Welsh PA, Budgeon LR, Wigdahl B, Howett MK.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):454-60.

PMID:
14657754
33.

Studying child abuse and neglect in Canada: we are just at the beginning.

Ward MG, Bennett S.

CMAJ. 2003 Oct 28;169(9):919-20. No abstract available.

34.

Suppression of human papillomavirus gene expression in vitro and in vivo by herpes simplex virus type 2 infection.

Fang L, Ward MG, Welsh PA, Budgeon LR, Neely EB, Howett MK.

Virology. 2003 Sep 15;314(1):147-60.

35.

Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome.

McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK.

Am J Gastroenterol. 2003 Mar;98(3):671-8.

PMID:
12650805
36.

A preventable cause of brachial plexus injury.

Wong DH, Ward MG.

Anesthesiology. 2003 Mar;98(3):798. No abstract available.

PMID:
12606936
37.

Use of an alloreactive lymphocyte vaccine to prolong rat cardiac allograft survival.

Shallat J, Blanchard JM, Ward MG, Pollak R.

Transplant Proc. 2000 May;32(3):657-9. No abstract available.

PMID:
10812155
38.

Transforming growth factor beta 1 (TGF beta 1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells.

Shier MK, Neely EB, Ward MG, Meyers C, Howett MK.

Anticancer Res. 1999 Nov-Dec;19(6B):4977-82.

PMID:
10697499
39.

Correlation of TGF beta 1 overexpression with down-regulation of proliferation-inducing molecules in HPV-11 transformed human tissue xenografts.

Shier MK, Neely EB, Ward MG, Richards ME, Manders EC, Meyers C, Howett MK.

Anticancer Res. 1999 Nov-Dec;19(6B):4969-76.

PMID:
10697498
40.

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Howett MK, Neely EB, Christensen ND, Wigdahl B, Krebs FC, Malamud D, Patrick SD, Pickel MD, Welsh PA, Reed CA, Ward MG, Budgeon LR, Kreider JW.

Antimicrob Agents Chemother. 1999 Feb;43(2):314-21.

41.

Intrasplenic hepatocyte allotransplantation in dalmation dogs with and without cyclosporine immunosuppression.

Benedetti E, Kirby JP, Asolati M, Blanchard J, Ward MG, Williams R, Hewett TA, Fontaine M, Pollak R.

Transplantation. 1997 May 15;63(9):1206-9.

PMID:
9158010
42.

Conus medullaris injury following both tetracaine and lidocaine spinal anesthesia.

Waters JH, Watson TB, Ward MG.

J Clin Anesth. 1996 Dec;8(8):656-8.

PMID:
8982894
43.

Transplantation of hepatocytes: an in-vitro and in-vivo study in canines.

Rivas PA, Fabrega AJ, Schwartz D, Dagiantis W, Ward MG, Blanchard J, Pollak R.

Cell Transplant. 1994 Mar-Apr;3(2):193-201.

PMID:
8012735
44.

Grazing selectivity and in vivo digestibility of switchgrass strains selected for differing digestibility.

Ward MG, Ward JK, Anderson BE, Vogel KP.

J Anim Sci. 1989 Jun;67(6):1418-24.

PMID:
2768099
45.

Placental transfer of ephedrine does not affect neonatal outcome.

Hughes SC, Ward MG, Levinson G, Shnider SM, Wright RG, Gruenke LD, Craig JC.

Anesthesiology. 1985 Aug;63(2):217-9. No abstract available.

PMID:
4025872
46.

Effect of formulation on the viability of Metarhizium anisopliae conidia.

Daoust RA, Ward MG, Roberts DW.

J Invertebr Pathol. 1983 Mar;41(2):151-60. No abstract available.

PMID:
6841995
47.

Complications of antifibrinolysis therapy after prostatectomy.

Ward MG, Richards B.

Br J Urol. 1979 Jun;51(3):211-2.

PMID:
465989
49.

Reversibility of steroid delta-isomerase. 3. The soluble enzyme of Pseudomonas testosteroni.

Ward MG, Engel LL.

J Biol Chem. 1966 Jul 10;241(13):3154-7. No abstract available.

50.

A CONVENIENT SYNTHESIS OF 3-BETA-HYDROXYANDROST-4-EN-17 ONE.

WARD MG, ORR JC, ENGEL LL.

J Org Chem. 1965 May;30:1421-3. No abstract available.

PMID:
14290373

Supplemental Content

Support Center